RQ Bio

London, United Kingdom

RQ Bio is a biotechnology company that develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections.

Jun 2026

Series A

Top Investors

Wellington ManagementOxford Science EnterprisesUniversity of OxfordForbion Capital PartnersFrazier Life Sciences

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are RQ Bio's investors?

RQ Bio's investors include Wellington Management, Oxford Science Enterprises, University of Oxford, Forbion Capital Partners, Frazier Life Sciences.

Where is RQ Bio headquartered?

RQ Bio is headquartered in London, United Kingdom.

What does RQ Bio do?

RQ Bio is a biotechnology company that develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections.

What stage is RQ Bio at?

RQ Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 24, 2026.

MLA

"RQ Bio — Funding & Investors." VCBacked, June 24, 2026, https://www.vcbacked.co/company/rq-bio. Accessed June 30, 2026.

APA

VCBacked. (2026). RQ Bio — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/rq-bio

Wikipedia (cite web)

{{cite web |title=RQ Bio — Funding & Investors |url=https://www.vcbacked.co/company/rq-bio |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 24, 2026.